Fig. 1From: Predictors of good response to conventional synthetic DMARDs in early seronegative rheumatoid arthritis: data from the ESPOIR cohortFlowchart of ESPOIR cohort’s patients. RA, rheumatoid arthritis; RA+, ACR/EULAR classification for RA fulfilled; RA−, ACR/EULAR classification for RA not fulfilled; seronegative, both rheumatoid factor- and CCP-tests negative; seropositive, at least 1 positive test from rheumatoid factor- and CCP-testsBack to article page